Abiopharma

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EDGEMOND JAMES 🟡 adjusted position in 10.0K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $578.76 ($8.4M) Transaction Date: Apr 30, 2026 | Filing ID: 000014

Butler Dean Warren 🟢 acquired 152 shares of SILICON LABORATORIES INC. (SLAB) at $86.46 Transaction Date: Apr 30, 2026 | Filing ID: 029404

(99% Neutral) BRIDGEMARQ REAL ESTATE SVC INC. (ARQ) Announces Executive Changes

Director Woung-Chapman Marguerite 🟢 acquired 1.5K shares of Chord Energy Corp (CHRD) Transaction Date: Apr 29, 2026 | Filing ID: 000006

Director Paul Elaine 🟢 acquired 110.5K shares of Sabre Corp (SABR) at $1.81 Transaction Date: Apr 29, 2026 | Filing ID: 029403

Northrop Grumman Honors Top Suppliers Driving Industrial Innovation

(10% Negative) GIGCAPITAL7 CORP. (GIGGU) Announces Business Combination

Director Moraeus Hanssen Maria 🟢 acquired 3.4K shares of SLB LIMITED/NV (SLB) Transaction Date: May 01, 2026 | Filing ID: 000103

UTHR: Notification

(99% Neutral) AVITA MEDICAL, INC. (RCEL) Announces Regulatory Update

Menendez Sergio Mauricio 🟢 acquired 82.3K shares of CEMEX SAB DE CV (CX) Transaction Date: May 01, 2026 | Filing ID: 000003

OCEANAGOLD CORP (OGC) Files Form 6-K

📋 Warmuth Markus (Officer) plans to sell 5K shares of Monte Rosa Therapeutics, Inc. (at $18,922.01 each, total $103.4M) Filed: May 01, 2026 | ID: 000046

📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 13K shares of Werewolf Therapeutics, Inc. (at $0.72 each, total $9K) Filed: May 01, 2026 | ID: 029397